Max Vaynrub, MD

About Me

I am a surgeon who specializes in caring for people with musculoskeletal cancers, including primary and metastatic bone cancer, soft tissue sarcoma, and tumors of the spine. I have particular expertise in using minimally invasive techniques and treating tumors in difficult locations, such as the spine and pelvis. I strive to provide my patients with the best surgical outcome. An important part of this goal is to maximize postoperative function and minimize pain after surgery. My practice is located at Memorial Hospital in Manhattan and at MSK Monmouth.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Spinal and pelvic tumors are often structurally complex, and surgery can be challenging. For this reason, I have trained in both musculoskeletal oncology and spine surgery. I have extensive experience in managing complicated bone and muscle tumors, navigating intricate spinal anatomy, and performing durable spinal reconstruction. This allows me to provide my patients with the specialized care that these complex tumors require.

Technology plays a critical role in treating musculoskeletal cancers. Advances in real-time surgical navigation and postoperative radiation treatments enable us to target cancer with increased precision. We use the most up-to-date techniques in skeletal reconstruction. I work with a team of specialists, including radiation oncologists, medical oncologists, pathologists, and interventional radiologists. Together, we ensure that our patients receive the most current treatment in each field. All of this combined means that patients are experiencing better functional outcomes than ever before.

I am deeply aware of the anxiety and uncertainty that patients and their families may feel when they receive a diagnosis of cancer. This is especially true for rare diagnoses, such as sarcoma and spinal tumors, for which they may not have been able to find much definitive information. I spend as much time as necessary with each patient and their family to ensure that they understand the specifics of their disease. Once everyone is comfortable with the information provided, we will work to create an optimal treatment plan based on their individual needs and goals.

  • Clinical Expertise: Pediatric and Adult Bone and Soft Tissue Sarcomas; Spine Tumors; Tumors of the Pelvis and Sacrum; Metastatic Bone Cancer; Benign Bone Tumors; Osteoporosis; Degenerative Disease of the Spine; Spine Deformity; Limb Salvage Surgery; Sacrectomy; Joint Replacement; Amputation; Minimally Invasive Spine Surgery
  • Languages Spoken: English; Spanish; Russian
  • Education: MD, New York University School of Medicine
  • Residencies: Orthopaedic Surgery – Los Angeles County + University of Southern California Medical Center
  • Fellowships: Musculoskeletal Oncology – Memorial Sloan Kettering Cancer Center; Orthopaedic Spine Surgery – NYU Langone Hospital for Joint Diseases

See My Colleagues


Vaynrub, M, Taheri N, Ahlmann E, Yao C, Fedenko AN, Allison DC, Chawla SP, Menendez L. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma. Journal of Surgical Oncology. 2015;111:152-157.

Janjua MB, Tishelman J, Vaynrub M*, Zhou P, Errico TJ, Buckland AJ, Protopsaltis TS (*, presenting author). The Value of Sitting Radiographs: Analysis of Spine Flexibility and its Utility in Preoperative Planning of Adult Spinal Deformity Surgery. Podium and poster presentations at: AOSpine North America Banff Fellowship Forum; Alberta, Canada. March, 2017.

Vaynrub M, Healey JH. Chapter 3: Importance of relative chemo, hormonal, and immunosensitivity. In: Marco RA. Metastatic Spine Disease: A guide to diagnosis and management.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Visit PubMed for a full listing of Max Vaynrub’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.